Yasuda Tsukasa, Hiraga Junji, Narita Michihiko, Tanikawa Yoshimasa, Tsuzuki Tomoyuki
Department of Gastroenterology, Toyota Kosei Hospital, Toyota, Japan.
Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.
Case Rep Hematol. 2021 Aug 26;2021:9965371. doi: 10.1155/2021/9965371. eCollection 2021.
The case of a 76-year-old man with multiple primary cancers that were treated with nivolumab is presented. Six years earlier, he was diagnosed with multiple myeloma (MM) and was treated with several chemotherapies. He was also diagnosed with gastric cancer with liver metastasis and primary lung cancer by upper gastrointestinal endoscopy and computed tomography (CT). Nivolumab treatment was given as third-line therapy, and it was effective for gastric and lung cancers. But MM worsened, and the patient died. There is no standard treatment for multiple primary cancers, and the development of effective treatments for multiple primary cancers is important.
本文介绍了一名76岁患有多种原发性癌症并接受纳武单抗治疗的男性病例。六年前，他被诊断出患有多发性骨髓瘤（MM），并接受了多种化疗。通过上消化道内镜检查和计算机断层扫描（CT），他还被诊断出患有伴有肝转移的胃癌和原发性肺癌。纳武单抗治疗作为三线治疗方案，对胃癌和肺癌有效。但MM病情恶化，患者死亡。目前尚无针对多种原发性癌症的标准治疗方法，开发有效的多种原发性癌症治疗方法很重要。
